Your browser doesn't support javascript.
loading
Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.
Nitta, Ryan T; Bolin, Sara; Luo, Emily; Solow-Codero, David E; Samghabadi, Peyman; Purzner, Teresa; Aujla, Parvir S; Nwagbo, Ginikachi; Cho, Yoon-Jae; Li, Gordon.
  • Nitta RT; Department of Neurosurgery, Stanford University, Stanford, CA, USA. rnitta@stanford.edu.
  • Bolin S; Department of Neurosurgery, Stanford University, Stanford, CA, USA.
  • Luo E; Department of Neurosurgery, Stanford University, Stanford, CA, USA.
  • Solow-Codero DE; High-Throughput Bioscience Center, Department of Chemical and Systems Biology, Stanford University, Stanford, CA, USA.
  • Samghabadi P; Department of Neuropathology, Stanford University, Stanford, CA, USA.
  • Purzner T; Department of Developmental Biology, Stanford University, Stanford, CA, USA.
  • Aujla PS; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.
  • Nwagbo G; Department of Neurosurgery, Stanford University, Stanford, CA, USA.
  • Cho YJ; Department of Neurosurgery, Stanford University, Stanford, CA, USA.
  • Li G; Department of Pediatrics, Papé Family Pediatric Research Institute, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Oncogene ; 38(42): 6867-6879, 2019 10.
Article en En | MEDLINE | ID: mdl-31406250

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antineoplásicos Alquilantes / Quinasa de la Caseína II / Inhibidores Enzimáticos / Temozolomida / Meduloblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antineoplásicos Alquilantes / Quinasa de la Caseína II / Inhibidores Enzimáticos / Temozolomida / Meduloblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article